Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Oct 27, 2020

SELL
$13.97 - $21.16 $34,925 - $52,900
-2,500 Closed
0 $0
Q2 2020

Jul 22, 2020

SELL
$10.39 - $16.07 $36,365 - $56,245
-3,500 Reduced 58.33%
2,500 $3,000
Q4 2017

Jan 17, 2018

SELL
$3.9 - $4.66 $44,460 - $53,124
-11,400 Reduced 65.52%
6,000 $0
Q3 2017

Oct 17, 2017

BUY
$4.14 - $5.12 $72,036 - $89,088
17,400
17,400 $11,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $101M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.